These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23106778)

  • 1. Post-docking optimization and analysis of protein-ligand interactions of estrogen receptor alpha using AMMOS software.
    Pencheva T; Jereva D; Miteva MA; Pajeva I
    Curr Comput Aided Drug Des; 2013 Mar; 9(1):83-94. PubMed ID: 23106778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMMOS: Automated Molecular Mechanics Optimization tool for in silico Screening.
    Pencheva T; Lagorce D; Pajeva I; Villoutreix BO; Miteva MA
    BMC Bioinformatics; 2008 Oct; 9():438. PubMed ID: 18925937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VISCANA: visualized cluster analysis of protein-ligand interaction based on the ab initio fragment molecular orbital method for virtual ligand screening.
    Amari S; Aizawa M; Zhang J; Fukuzawa K; Mochizuki Y; Iwasawa Y; Nakata K; Chuman H; Nakano T
    J Chem Inf Model; 2006; 46(1):221-30. PubMed ID: 16426058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
    Deng Z; Chuaqui C; Singh J
    J Med Chem; 2004 Jan; 47(2):337-44. PubMed ID: 14711306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.
    Perola E; Walters WP; Charifson PS
    Proteins; 2004 Aug; 56(2):235-49. PubMed ID: 15211508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing false positives in kinase virtual screens.
    Perola E
    Proteins; 2006 Aug; 64(2):422-35. PubMed ID: 16708364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it possible to increase hit rates in structure-based virtual screening by pharmacophore filtering? An investigation of the advantages and pitfalls of post-filtering.
    Muthas D; Sabnis YA; Lundborg M; Karlén A
    J Mol Graph Model; 2008 Jun; 26(8):1237-51. PubMed ID: 18203638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Monte Carlo-based receptor ensemble docking to virtual screening for GPCR ligands.
    Vilar S; Costanzi S
    Methods Enzymol; 2013; 522():263-78. PubMed ID: 23374190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Middle-way flexible docking: Pose prediction using mixed-resolution Monte Carlo in estrogen receptor α.
    Spiriti J; Subramanian SR; Palli R; Wu M; Zuckerman DM
    PLoS One; 2019; 14(4):e0215694. PubMed ID: 31013302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it possible docking and scoring new ligands with few experimental data? Preliminary results on estrogen receptor as a case study.
    Cozzini P; Dottorini T
    Eur J Med Chem; 2004 Jul; 39(7):601-9. PubMed ID: 15236840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FlexE: efficient molecular docking considering protein structure variations.
    Claussen H; Buning C; Rarey M; Lengauer T
    J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMMOS2: a web server for protein-ligand-water complexes refinement via molecular mechanics.
    Labbé CM; Pencheva T; Jereva D; Desvillechabrol D; Becot J; Villoutreix BO; Pajeva I; Miteva MA
    Nucleic Acids Res; 2017 Jul; 45(W1):W350-W355. PubMed ID: 28486703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases.
    Floriano WB; Vaidehi N; Zamanakos G; Goddard WA
    J Med Chem; 2004 Jan; 47(1):56-71. PubMed ID: 14695820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprocessing of docked protein-ligand complexes using implicit solvation models.
    Lindström A; Edvinsson L; Johansson A; Andersson CD; Andersson IE; Raubacher F; Linusson A
    J Chem Inf Model; 2011 Feb; 51(2):267-82. PubMed ID: 21309544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
    Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M
    J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lead finder: an approach to improve accuracy of protein-ligand docking, binding energy estimation, and virtual screening.
    Stroganov OV; Novikov FN; Stroylov VS; Kulkov V; Chilov GG
    J Chem Inf Model; 2008 Dec; 48(12):2371-85. PubMed ID: 19007114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of several molecular docking programs: pose prediction and virtual screening accuracy.
    Cross JB; Thompson DC; Rai BK; Baber JC; Fan KY; Hu Y; Humblet C
    J Chem Inf Model; 2009 Jun; 49(6):1455-74. PubMed ID: 19476350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and crystal structure of a phosphorylated estrogen receptor ligand binding domain.
    Möcklinghoff S; Rose R; Carraz M; Visser A; Ottmann C; Brunsveld L
    Chembiochem; 2010 Nov; 11(16):2251-4. PubMed ID: 20922740
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands.
    Wolohan P; Reichert DE
    J Mol Graph Model; 2004 Sep; 23(1):23-38. PubMed ID: 15331051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.